(A) Cardiovascular Disease and (B) type-2 Diabetes Mellitus, and (C) chronic kidney disease- related Age-Adjusted Mortality Rates per 100,000 in Adults in the United States, 1999 t... by Aman Goyal (19231397)

Overexpression of TNFAIP9 counteracted the renal damage caused by 5/6 Nx in C57 mice. by Ying Chen (9697)

SEM images of alkali-activated samples JW1 and JW3 at a magnification of ×1000. by Liang Li (46069)

SEM images of alkali-activated samples JW1 and JW3 at a magnification of ×1000. by Liang Li (46069)

(a) Changes of Fe-Al bond-bound soil organic carbon (Fe/Al-SOC) content during acification of black soil. (b) Changes of Calcium bond-bound soil organic carbon (Ca-SOC) content dur... by Xiaoxu Zhu (11764430)

Overexpression of TNFAIP9 inhibited the TNF-α-induced inflammation in HK-2 cells. by Ying Chen (9697)

a. Positive ion multi-dimensional analysis chart (A) Mild PTOA group VS Severe PTOA group (B) Mild PTOA group VS normal group (C) Severe PTOA group VS Normal group (a) 3D PCA score... by Peng-fei Han (694841)

Sociodemographic characteristics. by Hea Ree Park (10769827)

“…Increased circadian preference for eveningness and social jet lag were noted. A significant decrease in sleep duration and sleep efficiency, along with an increased prevalence of insomnia and daytime sleepiness, was noted with age- and sex-specific variations.…”

Study flow chart. by Hea Ree Park (10769827)

“…Increased circadian preference for eveningness and social jet lag were noted. A significant decrease in sleep duration and sleep efficiency, along with an increased prevalence of insomnia and daytime sleepiness, was noted with age- and sex-specific variations.…”

Enrollment flow-chart. by Marco Carbonara (11483575)

Subjects:

Optic Nerve Sheath Diameter (ONSD) in mm, measured by ultrasound. by Marco Carbonara (11483575)

Subjects:

ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

Subjects:

Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US. by Marco Carbonara (11483575)

Subjects:

Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

(A) Time spent in closed arm, (B) Time spent in open arm, (C) Number of entries in closed arm, (D) Number of entries in open arm, and (E) Latency time to enter open arm for elevate... by Hammad Ismail (4227988)

Table 1_Group B Streptococcus vaginal colonisation throughout pregnancy is associated with decreased Lactobacillus crispatus and increased Lactobacillus iners abundance in the vagi... by Toby I. Maidment (15296219)

Change in the ERCC1 secretion level in plasma(pg/ml). by Hao Deng (409186)

S1 Data - by Hao Deng (409186)

“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”